FDA recall record

AMS Diagnostics Medica ISE Module Calibrant A recall — FDA Z-2725-2017

Lot was not functioning properly and not exhibiting the correct physical properties.

Class IIIclassification
Z-2725-2017official record ID
Jul 19, 2017report date

Recall record at a glance

Official recordZ-2725-2017
CategoryMedical Device Recalls
ClassificationClass III
FDA record statusOngoing
Recalling firmAMS Diagnostics, LLC
Report dateJul 19, 2017
Recall initiation dateFeb 29, 2016
Quantity9 units
LocationWeston, FL, United States

Official product description

Medica ISE Module Calibrant A; 500 mL - 140 mmol/L Na+, 125 mmol/L Cl-, buffers and preservatives; For use with ISE Module; Product Usage: Calibrations of ISE Model for integrated electrolyte system analysis.

Why the product was recalled

Lot was not functioning properly and not exhibiting the correct physical properties.

Distribution information

US Nationwide Distribution in the states of AZ, CA, FL, MI, NC, NY, and SC.

How to read the classification

FDA Class III generally covers situations in which use of or exposure to the product is not likely to cause adverse health consequences. The classification displayed here is taken from the FDA enforcement record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Telephone.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.